Stocks News

LAST PRICE
51.7200
TODAY'S CHANGE (%)
Trending Up1.1000 (2.1731%)

Bid / Lots
48.1500/ 1
Ask / Lots
54.9900/ 5
Open / Previous Close
52.2600 / 50.6200
Day Range
Low 51.2200
High 54.5600
52 Week Range
Low 30.7400
High 75.1000
Volume
642,585
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- Stifel Adjusts Price Target on Arcellx to $83 From $82, Maintains Buy Rating, from 9 hours ago by MT Newswires
  9 hours ago by MT Newswires
  Companies Mentioned: ACLX
  07:21 AM EDT, 05/15/2024 (MT Newswires) -- Arcellx (ACLX) has an average buy rating and a price target range of $73 to $87, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major banks and...
- DJ Arcellx Is Maintained at Buy by Stifel, from 9 hours ago by Dow Jones
  9 hours ago by Dow Jones
  Companies Mentioned: ACLX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ACLX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 15, 2024 06:58 ET (10:58 GMT)
Yesterday
- Evercore ISI Starts Arcellx With Outperform Rating, from 8:00AM ET on Tuesday May 14, 2024 by MT Newswires
  8:00AM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: ACLX
  08:00 AM EDT, 05/14/2024 (MT Newswires) -- Arcellx (ACLX) has an average rating of buy and price targets ranging from $73 to $87, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major ban...
- DJ Arcellx Initiated at Outperform by Evercore ISI Group, from 5:29AM ET on Tuesday May 14, 2024 by Dow Jones
  5:29AM ET on Tuesday May 14, 2024 by Dow Jones
  Companies Mentioned: ACLX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ACLX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 14, 2024 05:29 ET (09:29 GMT)
May 13, 2024
- DJ Arcellx Is Maintained at Buy by HC Wainwright & Co., from 1:50PM ET on Monday May 13, 2024 by Dow Jones
  1:50PM ET on Monday May 13, 2024 by Dow Jones
  Companies Mentioned: ACLX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ACLX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 13, 2024 13:50 ET (17:50 GMT)

Today
- Avidity Biosciences Announces Appointment of Simona Skerjanec to Board of Directors, from 7 hours ago by PR Newswire
  7 hours ago by PR Newswire
  Companies Mentioned: RNA
Yesterday
- Vicore Expands and Strengthens its Board of Directors, from 2:20AM ET on Tuesday May 14, 2024 by Accesswire
  2:20AM ET on Tuesday May 14, 2024 by Accesswire
  Companies Mentioned: MACK, MXCT, RNA, KRON, PHVS, TBIO
May 13, 2024
- Merus Says US FDA Grants Breakthrough Therapy Designation for Petosemtamab, from 9:58AM ET on Monday May 13, 2024 by MT Newswires
  9:58AM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: MRUS
- Petosemtamab granted Breakthrough Therapy Designation by the U.S. FDA, from 8:00AM ET on Monday May 13, 2024 by GlobeNewswire
  8:00AM ET on Monday May 13, 2024 by GlobeNewswire
  Companies Mentioned: MRUS
May 9, 2024
- Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights, from 4:05PM ET on Thursday May 09, 2024 by PR Newswire
  4:05PM ET on Thursday May 09, 2024 by PR Newswire
  Companies Mentioned: RNA
- Rhythm Pharmaceuticals Announces New Employment Inducement Grants, from 4:01PM ET on Thursday May 09, 2024 by GlobeNewswire
  4:01PM ET on Thursday May 09, 2024 by GlobeNewswire
  Companies Mentioned: RYTM
- Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises, from 8:49AM ET on Thursday May 09, 2024 by MT Newswires
  8:49AM ET on Thursday May 09, 2024 by MT Newswires
  Companies Mentioned: NTLA
- Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress, from 7:30AM ET on Thursday May 09, 2024 by GlobeNewswire
  7:30AM ET on Thursday May 09, 2024 by GlobeNewswire
  Companies Mentioned: NTLA
May 8, 2024
- -- Earnings Flash (MRUS) MERUS N.V. Posts Q1 Revenue $7.9M, from 4:27PM ET on Wednesday May 08, 2024 by MT Newswires
  4:27PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: MRUS
- Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update, from 4:16PM ET on Wednesday May 08, 2024 by GlobeNewswire
  4:16PM ET on Wednesday May 08, 2024 by GlobeNewswire
  Companies Mentioned: MRUS

Arcellx Inc
NASDAQ:ACLXUnited States

Search Criteria

Today

Stifel Adjusts Price Target on Arcellx to $83 From $82, Maintains Buy Rating, from 9 hours ago by MT Newswires

DJ Arcellx Is Maintained at Buy by Stifel, from 9 hours ago by Dow Jones

Yesterday

Evercore ISI Starts Arcellx With Outperform Rating, from 8:00AM ET on Tuesday May 14, 2024 by MT Newswires

DJ Arcellx Initiated at Outperform by Evercore ISI Group, from 5:29AM ET on Tuesday May 14, 2024 by Dow Jones

May 13, 2024

DJ Arcellx Is Maintained at Buy by HC Wainwright & Co., from 1:50PM ET on Monday May 13, 2024 by Dow Jones

Peers Headlines

Today

Avidity Biosciences Announces Appointment of Simona Skerjanec to Board of Directors, from 7 hours ago by PR Newswire

Yesterday

Vicore Expands and Strengthens its Board of Directors, from 2:20AM ET on Tuesday May 14, 2024 by Accesswire

May 13, 2024

Merus Says US FDA Grants Breakthrough Therapy Designation for Petosemtamab, from 9:58AM ET on Monday May 13, 2024 by MT Newswires

Petosemtamab granted Breakthrough Therapy Designation by the U.S. FDA, from 8:00AM ET on Monday May 13, 2024 by GlobeNewswire

May 9, 2024

Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights, from 4:05PM ET on Thursday May 09, 2024 by PR Newswire

Rhythm Pharmaceuticals Announces New Employment Inducement Grants, from 4:01PM ET on Thursday May 09, 2024 by GlobeNewswire

Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises, from 8:49AM ET on Thursday May 09, 2024 by MT Newswires

Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress, from 7:30AM ET on Thursday May 09, 2024 by GlobeNewswire

May 8, 2024

-- Earnings Flash (MRUS) MERUS N.V. Posts Q1 Revenue $7.9M, from 4:27PM ET on Wednesday May 08, 2024 by MT Newswires

Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update, from 4:16PM ET on Wednesday May 08, 2024 by GlobeNewswire